Pseudomonas aeruginosa: the making of a pathogen by Lorenzo, Víctor de
 1	  
Highlight  1	  
 2	  
Pseudomonas aeruginosa: the making of a pathogen 3	  
 4	  
Víctor de Lorenzo, Systems Biology Program, Centro Nacional de Biotecnología CSIC, Campus de 5	  
Cantoblanco, Madrid, 28049 (Spain) 6	  
 7	  
Comment on Hilker et al. (2015) Interclonal gradient of virulence in the Pseudomonas aeruginosa 8	  
pangenome from disease and environment  9	  
 10	  
 11	  
What makes a bacterial pathogen be a pathogen? Simple as it sounds, this question is not at all trivial 12	  
to tackle as it is plagued with man-made pre-conceptions and often erroneous interpretative 13	  
frameworks. One can intuitively grasp the term pathogen as something that does wrong e.g. causes 14	  
infectious diseases to humans and by extension, to plants and animals. But let us face it: defining a 15	  
fundamental biological phenomenon on the sole basis of how much it affects us, human beings (and 16	  
animals and plants of importance to us), does not look like a sound scientific criterium. Only the 17	  
extremes are well delineated. At one of the ends we could consider clearly beneficial microbes with 18	  
little or no reputation of having ever caused damage to us, e.g. Lactobacillus acidophilus or 19	  
Bifidobacterium. At the other end we have genuinely virulent species such as Salmonella typhimurium, 20	  
Shigella flexneri, Yersinia pestis, etc., -not to mention enteroinvasive, enteropathogenic or 21	  
enterohemorrhagic E. coli, that make their living by doing harm to their potential hosts. But there is an 22	  
ample grey zone between the extremes of the scale where the frontier between being virulent or not is 23	  
more fuzzy. This is the territory of the so-called opportunistic pathogens –commensals by default that 24	  
at some point adopt an aggressive interplay with their hosts because of endogenous or exogenous 25	  
signals and circumstances. 26	  
 27	  
The frequent textbook view of opportunistic virulence is that practically all microbes with ecological 28	  
compatibility with a given host (for instance able to grow at body temperature) have the potential to 29	  
become pathogens. The immune system would thus be the only barrier for them not to deploy a 30	  
hostile behaviour (Fauci and Morens, 2012). This would account for why otherwise inoffensive 31	  
microorganisms that reside in diverse body niches may become pathogenic in immune-compromised 32	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or otherwise stressed individuals. Also, some pathogenic species that are trapped within a complex 1	  
net of interactions within a commensal consortium can take over upon e.g. antibiotic treatment. But 2	  
this common wisdom has some pitfalls. For instance, we co-exist intimately with Archaea (Cavicchioli, 3	  
2011) but they seem to be innocuous to us. They are found as a major component of our normal 4	  
microbial flora, being present in typical locations e.g. the gut and dental plaque. But despite our 5	  
closeness to them and ample evolutionary opportunities, there is no conclusive evidence that Archaea 6	  
can cause infections (Cavicchioli et al., 2003; Perez-Chaparro et al., 2014). A number of explanations 7	  
have been proposed, some of them related to our biochemical incompatibility with them (Sadhukhan 8	  
and Raghunathan, 2014), an issue that I will return to later.  9	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It is common to blame bacteria with a pathogenic lifestyle because they possess specific traits 11	  
allowing penetration in a target tissue to the detriment of the whole afflicted organism. But what are 12	  
such traits and how we can recognize them? The onset of easy DNA sequence has placed the 13	  
emphasis on identification of the so-called virulence factors. These are gene products that can be 14	  
discerned as specifically evolved to benefit from a host by escaping its defences and submitting the 15	  
targets’s resources to the pathogen’s exploitation. Since the pioneering work of S. Falkow in the early 16	  
1980s (Finlay and Falkow, 1989) a large number of such factors (mostly proteins) have been identified 17	  
that improve colonization of a new niche in the host (e.g. attachment), enable escape (or active 18	  
suppression) of the immune response, allow penetration of the bacteria (or proteins thereof) in the 19	  
target cells, and other amazingly intricate mechanisms. Screening for genes that determine virulence 20	  
with in vivo expression technologies (IVET) or other methods often yield a large number of metabolic 21	  
genes, but these are largely ignored and attention is focused instead on the conspicuous molecular 22	  
weaponry represented by such factors (Handfield et al., 2000). Their presence in a given genome 23	  
often means instant classification as a virulent strain or species – with all the clinical and even 24	  
regulatory consequences that such a label may have. The prevailing tenet is thus that one species or 25	  
strain is virulent because it has virulence factors - and virulence factors are thus to be found in virulent 26	  
strains. But are genes of such factors the actual ID of pathogens? 27	  
 28	  
It is within this context of assumptions on what to expect in a bacterial pathogen that the paper of 29	  
Hilker et al. (2015) deploys its whole value. In this very interesting contribution, B. Tümmler’s team in 30	  
Hannover rolled its sleeves up and made a systematic comparative analysis of the actual virulence of 31	  
 3	  
a large number of Pseudomonas aeruginosa strains isolated from either patients infected with the 1	  
clones at stake (lungs, catheters, keratitis), or from the environment (soil, seawater, freshwater, 2	  
plants), the latter  with no previous record of having infected anything. All strains were then tested for 3	  
virulence in 3 different assays: infection of lettuce leaves, infection of larvae (Galleria mellonella) and 4	  
murine airway infection. The virulence of each strain in every test system was then ranked and the 5	  
genomes of the bacteria inspected for the presence of pathogenicity determinants. And here came the 6	  
surprises.  7	  
 8	  
First, the origin and previous lives of the strains under study made little difference as a predictor of 9	  
how they would do in the next infection rounds. Some strains isolated from badly damaged patients 10	  
did poorly in the standardized virulence tests, while others from the environment and unlikely to have 11	  
been recently infecting any eukaryotic target, turned out to be quite aggressive in the same assays. 12	  
The second revelation of Hilker et al. (2015) was that the degree of virulence among strains varied 13	  
enormously depending on the test system. This indicated that the constellation of traits that made P. 14	  
aeruginosa to be a pathogen for one host might be irrelevant for another. But the most striking result of 15	  
this work was that the genome of the strain that more consistently qualified as virulent in all assays 16	  
(the clone called F469) lacked any of the genes that would normally be expected in a pathogen.  17	  
 18	  
The take home lesson of this work is that there is more to virulence than the possession or not of a 19	  
panel of virulence factors. Taking for granted that they necessarily do harm (and that their absence 20	  
certify safety) could be in fact misleading. Consider for instance the strain P. fluorescens SBW25. This 21	  
is a growth-promoting plant colonizer that actively expresses a Type-III secretion system (T3SS) 22	  
during its interplay with the host (Jackson et al., 2005). While T3SSs are regarded as archetypal 23	  
virulence factors, it could well happen that the effectors injected by P. fluorescens SBW25 to the plant 24	  
cells modulate the host metabolism for the better, not for the worse (other plant-associated 25	  
Pseudomonas e.g. P. syringae do inject detrimental effectors; Lindeberg et al., 2012). Also, shocking 26	  
as it may look in first sight, P. aeruginosa infections have even been suggested to have a role in 27	  
defending the human host against cancer (Bernardes et al., 2013; Chakrabarty, 2014). Can we then 28	  
make a clear divide between good and bad bacteria on the only basis of their taxonomic ID and the 29	  
recognizable determinants encoded in their genome? 30	  
 31	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No question that virulence factors participate in the infection process, but are they the only players? 1	  
The clear answer of Hilker et al. (2015) is no. I have argued before (de Lorenzo, 2014) that focusing 2	  
on such factors to understand virulence is like being mesmerized by the technological details of 3	  
weaponry in a war – ignoring the economy, energy, food, water and other background problems where 4	  
many conflicts emerge. Metabolism is the economy of bacteria (and living systems in general) and it is 5	  
naïve to think that we can understand pathogenesis without paying attention to the metabolic 6	  
transactions, most often unnoticed, that happen between the host and the infectious agents. In an 7	  
unusual but very welcome twist, Hilker et al. (2015) also examine what they call metabolic competence 8	  
of the P. aeruginosa strains under examination i.e. the contents and ratios of the various pools of 9	  
NAD(P) and NAD(P)H. Interestingly, these figures vary tremendously among isolates and do depart 10	  
from textbook values. But it was not possible in this work to correlate such metabolic descriptors with 11	  
virulence profiles. This is not surprising, because the measures of NAD(P)/H were made on cells 12	  
growing in flasks on tryptic soy broth, which surely causes a physiological regime quite different of the 13	  
biochemical and nutritional conditions that bacteria experience in target tissues.  14	  
 15	  
The poorly studied links between central metabolic functions of microorganisms and their ability to 16	  
become pathogens should definitely receive more attention. Biochemical compatibility between the 17	  
infectious agent and the target (see e.g. the case of Archaea above) might be key. It is possible also 18	  
that metabolic adaptation of environmental bacteria to the endogenous or exogenous oxidative stress 19	  
that frame their existence outdoors becomes an asset to endure the action of macrophages (Yuk et 20	  
al., 2012) when entering a new host. By the same token, evolving resistance to the host defences can 21	  
facilitate a superior capacity of pathogens to expand their metabolism towards new compounds (de 22	  
Lorenzo, 2014). It cannot be casual that potentially virulent strains of P. aeruginosa (Alonso et al., 23	  
1999; Marin et al., 2003) or Mycobacteria (Cerniglia, 1993) are often found among the best 24	  
biodegraders of environmental pollutants The connections between chemical contamination and the 25	  
emergence of new pathogenic capacities in bacteria that inhabit such niches certainly need to be 26	  
explored in more detail. In the meantime, Hilker et al. (2015) truly puts a finger on an uneasy puzzle 27	  
that oblige us to rethink prefixed ideas on what virulence is.  28	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